Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer
Clinical trial NCT03088813 · COMPLETED
Trial details
- NCT number
- NCT03088813
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-25
- Primary completion
- 2022-02-08
- Enrollment
- 491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.